IE32804L - Preparation of (cis-1,2-epoxypropyl) phosphonic acid¹and derivatives - Google Patents
Preparation of (cis-1,2-epoxypropyl) phosphonic acid¹and derivativesInfo
- Publication number
- IE32804L IE32804L IE690635A IE63569A IE32804L IE 32804 L IE32804 L IE 32804L IE 690635 A IE690635 A IE 690635A IE 63569 A IE63569 A IE 63569A IE 32804 L IE32804 L IE 32804L
- Authority
- IE
- Ireland
- Prior art keywords
- alkyl
- acid
- salt
- compounds
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
1,266,611. Preparing (cis-1,2-epoxypropyl)- phosphonic acid and derivatives thereof. MERCK & CO. Inc. 12 May, 1969 [15 May, 1968; 27 Aug., 1968; 25 April, 1969], No. 23990/69. Headings C2C and C2P. (Cis-1,2-epoxypropyl)-phosphonic acid or a salt or ester thereof (I) is obtained by treating a 1,2-disubstituted n-propyl phosphonic acid or salt or ester thereof with a reagent capable of effecting epoxide ring closure, at least one of the substituents being OH or functionally equivalent oxygen-containing radical and the other of the said substituents being any leaving group that can be displaced under the reaction conditions. The starting phosphonic compound may have the formula CH 3 CHX<SP>1</SP>CHXP(O)(OR) 2 (II) wherein each R is H or a C 1 -C 5 alkyl, C 2 -C 5 alkenyl, mononuclear aryl or -aralkyl, a metal of Group Ia, IIa, Ib or IIb of the Periodic Table, an amine salt-forming cation, and X and X<SP>1</SP> are halo, hydroxy, azido, C 1 -C 5 alkanoyloxy, trihalomethyl substituted C 1 -C 5 alkanoyloxy, C 1 -C 5 alkylsulphonyloxy, aryl (alkaryl- or aralkyl-) sulphonyloxy, tri-(C 1 -C 5 alkyl) quaternary ammonium salt-forming group, N- cycloalkyl (or N-phenyl) di-(C 1 -C 5 alkyl) quaternary ammonium salt-forming group, di- (C 1 -C 5 ) alkyl sulphonium salt-forming group, aryloxy, aralkoxy, dialkoxyphosphino, N- (alkanesulphonyl) alkylamino or N-alkarylsulphonyl cycloalkylamino with the proviso that at least one of X and X<SP>1</SP> is hydroxy or functionally equivalent oxygen-containing radical. The ring closure may be effected by treating the starting material (which may be formed in situ) with (1) an acid, e.g. H 2 SO 4 , peracetic acid or nitrous acid; with a Lewis acid such as BF 3 or P 2 O 5 ; or with hexafluoroacetone in a protonic acid such as a mineral acid or p-toluene sulphonic acid, (2) with a solution of a metal or metal compound capable of forming metal ions in a neutral or acidic solution, e.g. with silver acetate in a mineral acid, e.g. HCl, (3) with a base having a pH equal to or greater than 7, or (4) by passing a solution of the starting material through an ion exchange column on the basic cycle. Different optically active isomers are obtained according to the particular optically active isomer used as starting material and epoxy formation occurs with a net inversion of the configuration at the carbon atom bearing the leaving substituent X or X<SP>1</SP>. The invention is more particularly directed to the production of ( ) and (-) (cis-1,2-epoxypropyl) phosphonic acid derivatives and when the product is an ester it may be converted to the free acid which may then be converted to a salt especially an alkali metal or alkaline earth metal salt by treatment with a base. The free ( ) and (-) cis-1,2-epoxypropyl phosphonic acid and salts thereof are useful antibacterial agents and may be formulated with diluents and conventional additives. They may be administered orally in capsule or tablet form or in a liquid solution or suspension or parenterally by injection in a sterile excipient. Several methods are described for preparing various types of starting materials of Formula II. Thus, the (1-hydroxy-2-organosulphonyl. oxypropyl) phosphonic compounds may be prepared by treating a compound: wherein R<SP>1</SP> is alkyl, aryl or aralkyl and X<SP>3</SP> is halogen, e.g. Cl or Br, with a phosphite P(OR) 3 and then reducing the resulting intermediate CH 3 CH(OSO 2 R<SP>1</SP>)C(O)P(O)(OR) 2 with a reducing agent, e.g. NaBH 4 . Compounds of Formula II in which X<SP>1</SP> is a dialkylsulphonium salt-forming radical may be obtained by the following reaction scheme: wherein R<SP>2</SP> is C 1 -C 5 alkyl, R<SP>1</SP>Z is an alkyl halide and Z<SP>(-)</SP> is a halogen anion. Starting compounds in which the sulphonium radical is bonded to the 1-carbon atom may be obtained by the following reaction: wherein R<SP>2</SP>SZ is a C 1 -C 5 alkylsulphenyl halide, R<SP>2</SP>X is a C 1 -C 5 alkyl halide, R<SP>3</SP> is C 1 -C 5 alkyl, R<SP>3</SP>COOM is a metal salt of a C 1 -C 5 alkanoic acid, X# is a halogen anion and R, R<SP>2</SP> and Z are as defined above. Compounds of the type in which an oxygen-containing radical is bonded to the 2-C atom, e.g. as in (IIb) below may be obtained by a reaction of the type: wherein R<SP>4</SP> is C 1 -C 5 alkyl, trihalomethyl, or trihalomethyl-substituted C 1 -C 5 alkyl. Compounds in which X is halogen in Formula II may be obtained by either (a) the following reaction: wherein R<SP>5</SP> is a hydrocarbyl radical or an alkali metal or alkaline earth metal and wherein the N-bromo-succinimide may be replaced by other functionally equivalent halogenating agents; or (b) by the following reaction sequences wherein X<SP>4</SP> is a halogen atom, this method being particularly suitable for the preparation of the ( ) threo (1-halo-2-hydroxypropyl) phosphonic acid (IIj) which may then be converted to the (+) threo derivative (IIm) by resolution as shown. Starting compounds in which the leaving group X is a substituted amino radical may be obtained by the following reaction: wherein R<SP>6</SP> is alkyl or mononuclear cycloalkyl, X<SP>2</SP> is a halogenating agent, H+ is the cation derived from an acid, and the chloroform is used as reaction medium for the halogenating agent. In another method the above intermediate compound VI is converted to the compound IIp below by the following reaction: wherein M, R and R<SP>6</SP> are as defined above and wherein other appropriate sulphonyl halides may also be used instead of the reagent shown. Compounds (II) in which the oxygen-containing radical is bonded to the 1-carbon atom may be obtained by the following reaction: with further reaction of the OH group on the 1-carbon atom with an appropriate organic acid halide if required. The starting compounds in which R is C 1 -C 5 alkyl, X is OH and X<SP>1</SP> is tri- (C 1 - 5 alkyl) quaternary ammonium or a di- (C 1 -C 5 alkyl) sulphonium salt forming group may be prepared by the latter reaction using compounds in which X<SP>1</SP> is NH 2 or (C 1 -C 5 alkyl) mercapto and then treating the product with a C 1 -C 5 alkyl halide. Compounds II may also be obtained by reacting a suitably substituted propionyl halide with a phosphite triester to form a (2-X<SP>1</SP>-substituted propionyl) phosphonate and then reducing the latter, e.g. with an alkali metal borohydride: Threo dimethyl - [1 - (phenylamino) - 2 - hydroxyprepyl] phosphonate is obtained by reacting cis-1-propenyl phosphonate with phenyl azide to form (1,2 - N - phenyliminopropyl) phosphonate and then treating the latter with 2N H 2 SO 4 at 40 C. Treatment of the product with methyl iodide in methanol, removal of the methanol, addition of benzene and its evaporation to azeotrope the reaction mixture to dryness, followed by further reaction with methyl iodide in benzene yields the corresponding N-phenyl dimethylammonium iodide derivative. Benzyl-2-tosyloxypropionate is obtained by reacting benzyl lactate (dissolved in benzene) with p-toluene sulphonyl chloride in the presence of pyridine and on hydrogenation over a Pd on charcoal catalyst yields 2-tosyloxypropionic acid which is then treated with thionyl chloride to form 2-tosyloxypropionyl chloride.
[GB1266611A]
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72942468A | 1968-05-15 | 1968-05-15 | |
| US75572968A | 1968-08-27 | 1968-08-27 | |
| US81944769A | 1969-04-25 | 1969-04-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32804L true IE32804L (en) | 1969-11-15 |
| IE32804B1 IE32804B1 (en) | 1973-12-12 |
Family
ID=27419130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE635/69A IE32804B1 (en) | 1968-05-15 | 1969-05-06 | Preparation of (cis-1,2-epoxypropyl)phosphonic acid and derivatives thereof |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS4919264B1 (en) |
| AR (1) | AR195479A1 (en) |
| AT (1) | AT306052B (en) |
| BE (1) | BE733050A (en) |
| CA (1) | CA939366A (en) |
| CH (1) | CH513924A (en) |
| DE (1) | DE1924169C3 (en) |
| ES (2) | ES367269A1 (en) |
| FI (1) | FI53216C (en) |
| FR (1) | FR2008620B1 (en) |
| GB (1) | GB1266611A (en) |
| IE (1) | IE32804B1 (en) |
| IL (1) | IL32180A0 (en) |
| NL (1) | NL6907465A (en) |
| YU (1) | YU120469A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4937367A (en) * | 1987-07-15 | 1990-06-26 | Zambon Group S.P.A. | Process for the preparation of intermediates for the synthesis of fosfomycin |
| CN114540619B (en) * | 2020-11-25 | 2024-02-13 | 厦门稀土材料研究所 | Functional ionic liquid and preparation method and application thereof |
-
1969
- 1969-05-06 IE IE635/69A patent/IE32804B1/en unknown
- 1969-05-06 IL IL32180A patent/IL32180A0/en unknown
- 1969-05-12 GB GB1266611D patent/GB1266611A/en not_active Expired
- 1969-05-12 CA CA051,319A patent/CA939366A/en not_active Expired
- 1969-05-12 DE DE1924169A patent/DE1924169C3/en not_active Expired
- 1969-05-14 FI FI1443/69A patent/FI53216C/fi active
- 1969-05-14 ES ES367269A patent/ES367269A1/en not_active Expired
- 1969-05-14 YU YU01204/69A patent/YU120469A/en unknown
- 1969-05-14 AT AT462869A patent/AT306052B/en not_active IP Right Cessation
- 1969-05-14 CH CH743369A patent/CH513924A/en not_active IP Right Cessation
- 1969-05-14 BE BE733050D patent/BE733050A/xx unknown
- 1969-05-14 NL NL6907465A patent/NL6907465A/xx not_active Application Discontinuation
- 1969-05-15 JP JP44037097A patent/JPS4919264B1/ja active Pending
- 1969-05-16 FR FR6915925A patent/FR2008620B1/fr not_active Expired
-
1971
- 1971-09-16 ES ES395161A patent/ES395161A1/en not_active Expired
-
1972
- 1972-02-11 AR AR240490A patent/AR195479A1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| FI53216B (en) | 1977-11-30 |
| FR2008620B1 (en) | 1975-10-31 |
| YU120469A (en) | 1979-10-31 |
| DE1924169B2 (en) | 1973-07-05 |
| DE1924169C3 (en) | 1974-02-21 |
| AR195479A1 (en) | 1973-10-15 |
| ES395161A1 (en) | 1974-11-16 |
| IL32180A0 (en) | 1969-07-30 |
| BE733050A (en) | 1969-11-14 |
| ES367269A1 (en) | 1972-02-16 |
| FR2008620A1 (en) | 1970-01-23 |
| JPS4919264B1 (en) | 1974-05-16 |
| FI53216C (en) | 1978-03-10 |
| GB1266611A (en) | 1972-03-15 |
| NL6907465A (en) | 1969-11-18 |
| AT306052B (en) | 1973-03-26 |
| IE32804B1 (en) | 1973-12-12 |
| CA939366A (en) | 1974-01-01 |
| DE1924169A1 (en) | 1970-02-05 |
| CH513924A (en) | 1971-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES250753A1 (en) | Process for the preparation of o,o-dialkyl-dithiophosphoryl-fatty acid compounds and pesticidal compositions containing the same | |
| US3903164A (en) | Pharmacodynamically active amino alkyloxim ethers | |
| IE32804B1 (en) | Preparation of (cis-1,2-epoxypropyl)phosphonic acid and derivatives thereof | |
| DE69619685T2 (en) | GALANTHAMINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| EP0190992A2 (en) | Perfluoroalkylthio, sulfonyl or sulfinyl alkyl glycidyl ethers, process for their preparation and their use | |
| DK682288D0 (en) | METHOD OF PREPARING QUINOLINCARBOXYL ACID | |
| US3134800A (en) | Amino aromatic phosphonates and process of preparation | |
| EP0299484A1 (en) | Process for the preparation of intermediates for the synthesis of fosfomycin | |
| US3846476A (en) | N-benzyloxycarbonyl-dopa derivatives | |
| US3887615A (en) | Novel butanoic acid derivatives | |
| ATE59387T1 (en) | 1,3-DIOXANE-4-YLALENE ACID. | |
| EP0146838B1 (en) | (alkylsulfonyl)methanesulfonates as anticancer agents | |
| US5055490A (en) | Stereoisomers of benzonitrile derivatives, useful as cardiac arrhythmiac agents | |
| DE3853311T2 (en) | Thiadiazolylacetamide cephem derivatives. | |
| ES8207505A1 (en) | Substituted phenoxy-aminopropanol derivatives, intermediates and processes for their production, and pharmaceutical preparations containing them. | |
| ES367096A1 (en) | A PROCEDURE FOR THE PREPARATION OF ACID (CIS-1,2-EPO-XIPROPYL) -PHOSPHONE OR AN ESTER OR SALT OF THE SAME. | |
| PT93675B (en) | PROCESS FOR THE PREPARATION OF DERIVATIVES OF UNATURATED AMINODYCARBOXYL ACIDS, CONTAINING PHOSPHORUS | |
| US2804460A (en) | Tropene derivatives | |
| FR2570699B1 (en) | NOVEL PROCESS FOR THE PREPARATION OF 4H-1,2,4-TRIAZOLE DERIVATIVES, NOVEL TRIAZOLES THUS OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| GB1061425A (en) | New benzofuran derivatives and process for preparing the same | |
| Alfer'Ev et al. | Reactions of vinylidenediphosphonic acid with nucleophiles. 4. Addition of amino acids, diastereotopy of phosphorus atoms in the addition products | |
| US3052709A (en) | Benzyl phosphoric acid ester compounds and process for making same | |
| EP0627416A4 (en) | PROCESS FOR PRODUCING PROSTAGLANDIN E. | |
| US3168514A (en) | Process for the preparation of aziridine phosphoryldifluorides | |
| BR8701694A (en) | PROCESS FOR THE PRODUCTION OF ALPHA-AMINOALKYLPHOSPHONIC ACIDS OR THEIR SALTS |